{
  "query": "cyclical risk management strategies for the ion beam technology sector",
  "timestamp": "2025-09-07 00:29:41",
  "config": {
    "top_k": 5,
    "similarity_threshold": 0.0,
    "reranking_enabled": true,
    "hybrid_search_enabled": true,
    "hybrid_search_weight": 0.7
  },
  "results": [
    {
      "id": 1,
      "text": "assessing \nperformance of the operating segments. On the basis of its internal financial reports and given the Groups primary source \nof risk and profitability, IBA has identified two operating segments: - \nProton therapy and other accelerators: This segment constitutes the technological basis of the Groups many \nbusinesses and encompasses development, fabrication, and services associated with medical and industrial \nparticle accelerators and proton therapy systems. - \nDosimetry: This segment in",
      "similarity_score": 0.39264535025546426
    }
  ]
}